PRESS RELEASE published on 12/20/2023 at 12:45, 2 years 4 months ago MindBio Therapeutics CEO Provides End of Year Video Update on Phase 2 Clinical Trials
PRESS RELEASE published on 11/21/2023 at 14:42, 2 years 5 months ago MindBio Therapeutics Team Members Honoured with Industry Leading Awards
PRESS RELEASE published on 10/31/2023 at 07:30, 2 years 6 months ago MindBio Therapeutics CEO Presents World First Phase 2B Take-Home Microdosing Clinical Trial in Cancer Patients
PRESS RELEASE published on 10/29/2023 at 03:00, 2 years 6 months ago MindBio Therapeutics Begins Dosing MB22001 in World First Phase 2B Microdosing Clinical Trial In Advanced Stage Cancer Patients
PRESS RELEASE published on 10/26/2023 at 14:50, 2 years 6 months ago Mindbio Therapeutics Nominated for Company of the Year in Industry Awards
PRESS RELEASE published on 10/24/2023 at 13:25, 2 years 6 months ago MindBio Therapeutics CEO Provides Video Update on Phase 2a Depression Trial Using MB22001
PRESS RELEASE published on 10/05/2023 at 11:29, 2 years 7 months ago Tenth Patient With Depression Starts Dosing MB22001 in Take Home Microdosing Trials
PRESS RELEASE published on 09/14/2023 at 15:45, 2 years 7 months ago Mindbio Therapeutics CEO Provides Update on Depression Trial & Novel Discoveries in Psychedelics Research
PRESS RELEASE published on 09/05/2023 at 11:50, 2 years 8 months ago MindBio Therapeutics Announces Major Genetic Discovery in Microdosing Research
PRESS RELEASE published on 08/24/2023 at 08:30, 2 years 8 months ago Begins Dosing Mb22001 in Phase 2 Clinical Trial in World First Take-Home Microdosing Study in Patients with Depression
Published on 05/07/2026 at 05:40, 2 hours 18 minutes ago New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 5 hours 58 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 8 hours 28 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 8 hours 53 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 8 hours 58 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/07/2026 at 07:35, 23 minutes ago Rare Watches Spark Frenzied Interest in FutureGrail's May Auction
Published on 05/07/2026 at 07:35, 23 minutes ago Lenzing delivers positive net result in Q1 2026 and significantly increases free cash flow
Published on 05/07/2026 at 07:31, 26 minutes ago Henkel delivers good organic sales growth in the first quarter of 2026
Published on 05/07/2026 at 07:30, 27 minutes ago Q1 2026: Solid start to the year confirms transformation strategy
Published on 05/07/2026 at 07:30, 27 minutes ago SGL Carbon: Expected lower sales, but EBITDA margin improved. Forecast confirmed
Published on 05/06/2026 at 18:00, 13 hours 58 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 13 hours 58 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 17:45, 14 hours 13 minutes ago Information concerning the total number of voting rights and shares 2026 04 30
Published on 05/06/2026 at 17:45, 14 hours 13 minutes ago Declaration of voting rights at the end of April 2026
